Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Bayer, Monsanto start $2.5 billion asset sale to get merger clearance - sources

Published 09/03/2017, 12:45
Updated 09/03/2017, 12:50
© Reuters. Monsanto logo is displayed on a screen where the stock is traded on the floor of the NYSE
DJI
-
DOW
-
BASFN
-
BAYGN
-
SYENF
-
DD
-
MON
-

FRANKFURT (Reuters) - German drug and crop chemical maker Bayer (DE:BAYGn) and U.S. seeds company Monsanto (N:MON) are launching asset sales worth roughly $2.5 billion (2.06 billion pounds) as they seek regulatory clearance for their $66 billion merger, people close to the matter said.

To kick off an auction process, Bayer's advisors will send out information packages next week to prospective bidders for the businesses, which have been divided into three bundles of assets, the people said.

Bayer and Monsanto have said in the past that they expect to divest activities with combined sales of up to $1.6 billion.

While it could not be learnt what businesses will be put on the auction block, antitrust and industry experts expect Bayer to potentially divest soybean, cotton and canola seed assets as well as LibertyLink-branded crops that are resistant to its glufosinate herbicide, an important alternative to Monsanto's Roundup Ready seeds.

Overall, regulatory hurdles to the deal are seen as manageable because Bayer's main business in agriculture is pesticides while Monsanto's focus is on genetically modified seeds.

Bayer said last month that it was on track to clear all regulatory hurdles for the takeover by year-end, including a likely in-depth investigation by the European Union's competition regulators.

Peer BASF (DE:BASFn) has been touted as a potential buyer of some of the assets after abstaining from a wave of consolidation in the agrochemicals industry, which also saw Dow (N:DOW) and DuPont (N:DD) merging and ChemChina buying Syngenta (S:SYNN).

The assets, which comprise sets of different active ingredients in several global regions, will also be shopped to large private equity groups, which may, however, struggle to bid competitively against players in the agricultural supplies market, the sources said.

"Transaction security is more important than price," one of the people close to Bayer said.

© Reuters. Monsanto logo is displayed on a screen where the stock is traded on the floor of the NYSE

Bayer and Monsanto declined to comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.